CorMedix (CRMD) Capital Expenditures Growth (3y) (2018 - 2025)
CorMedix (CRMD) Capital Expenditures Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -12.25% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | 137.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 137.28% |
| Sep 30, 2025 | 87.75% |
| Jun 30, 2025 | 34.40% |
| Mar 31, 2025 | 33.02% |
| Dec 31, 2024 | -74.74% |
| Sep 30, 2024 | -76.76% |
| Jun 30, 2024 | 83.63% |
| Mar 31, 2024 | 67.35% |
| Dec 31, 2023 | 56.58% |
| Sep 30, 2023 | -22.01% |
| Jun 30, 2023 | 16.35% |
| Mar 31, 2023 | 14.19% |
| Dec 31, 2022 | 139.02% |
| Sep 30, 2022 | 158.64% |
| Jun 30, 2022 | 41.17% |
| Mar 31, 2022 | -39.18% |
| Sep 30, 2021 | 317.77% |
| Jun 30, 2021 | 1,677.92% |
| Mar 31, 2021 | -30.06% |
| Dec 31, 2020 | -14.96% |